内血管外科神经瘤学:推进一个新的子专业
Christopher C Young1,2, Peter Kan1,2, Stephen R Chen3
1Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Journal of neuro-oncology
|September 2, 2024
概括
血管内外科神经瘤学利用先进的技术来管理脑瘤. 本综述探讨了历史和当前的内血管内动脉疗法,用于直接向神经系统瘤提供治疗.
科学领域:
- 神经瘤学神经瘤学
- 血管神经学 血管神经学
- 干预性放射学 干预性放射学
背景情况:
- 血管内外科神经瘤学是一个新兴领域.
- 它专注于管理神经系统瘤和相关的血管问题.
研究的目的:
- 审查40年来内血管内动脉治疗瘤的演变.
- 总结当前的内血管方法和正在进行的临床试验.
主要方法:
- 内血管技术的历史审查.
- 目前临床实践和研究的总结.
主要成果:
- 内血管方法越来越多地被探索,以向向脑瘤的药物输送.
- 克服血脑和血瘤屏障的方法正在研究中.
结论:
- 内血管技术为治疗神经系统瘤提供了有希望的途径.
- 进一步的研究和临床试验对于推进这一子专业至关重要.
相关概念视频
Veins of Head and Neck
1.6K
The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
1.6K
Inflammatory Bowel Disease V: Surgical Management
133
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
133
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


